SCHEMBL6827481

SCHEMBL6827481

COc1ccc(C(O[C@@H](CNC(=O)C(F)(F)F)[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RNASE1 P07998 1/20 0.36
TK1 P04183 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6830778 0.90 RNASE1 (0.36) RNASE1TK1
SCHEMBL6832169 0.88 RNASE1 (0.34) RNASE1TK1
SCHEMBL6830417 0.88 RNASE1 (0.34) RNASE1TK1
SCHEMBL439033 0.85 RNASE1 (0.39) RNASE1TK1
SCHEMBL26545363 0.85 RNASE1 (0.35) RNASE1TK1
SCHEMBL25511815 0.85 RNASE1 (0.38) RNASE1TK1
SCHEMBL2034479 0.82 RNASE1 (0.38) RNASE1TK1
SCHEMBL22984007 0.82 RNASE1 (0.40) RNASE1TK1
SCHEMBL9550769 0.82 RNASE1 (0.40) RNASE1TK1
SCHEMBL13930549 0.82 RNASE1 (0.40) RNASE1TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6743902-B1 FOR USE IN ANTISENSE THERAPY FOR ENHANCING NUCLEASE RESISTANCE AND CELLULAR UPTAKE VALEANT PHARMACEUTICALS INTERNATIONAL 2004-06-01 US disclosed
US-6191266-B1 MODIFIED TO COMPRISE SUBSTITUTIONS AT POSITIONS C1', C3', C4' OR C5' OF THE SUGAR MOIETY OF THE NUCLEOSIDE, INCLUDING AN OPTIONAL 3' PHOSPHOROAMIDITE GROUP; USE IN MAKING NUCLEASE RESISTANT OLIGONUCLEOTIDES FOR ANTISENSE THERAPY ICN PHARMACEUTICALS, INC. 2001-02-20 US disclosed
US-5712378-A SUGAR MOLECULE IS SUBSTITUTED WITH HYDROCARBON OR SUBSTITUTED HYDROCARBON GROUPS, ANTISENSE AGENTS ICN PHARMACEUTICALS (US) 1998-01-27 US disclosed